Literature DB >> 6157349

Enhancement of mouse natural killer cell activity by type II interferon.

A Senik, S Stefanos, J P Kolb, M Lucero, E Falcoff.   

Abstract

It is likely that interferons are key molecules in the physiological regulation of natural killing (NK) activity. This assumption is based on the strong enhancing effect exerted by type I interferon on NK cells. The aim of this study was to examine whether type II interferon, released upon activation of T lymphocytes by a mitogen, had the same enhancing effect. Crude PHA-induced interferon was purified on affinity chromatography columns (Blue Sepharose), and the eluted fractions were tested in parallel for antiviral activity and for in vitro boosting effect on spleen cell natural cytotoxicity. We found that both activities were unseparable. Acid pretreatment of purified type II interferon, as well as addition of anti-type II interferon serum, greatly decreased the enhancement of the spleen cell cytotoxic response. Responder cells to type II interferon are NK cells (surface Ig-negative, Thy-1-negative, devoided of acid Fc receptors) as assessed by classical spleen cell fractionation procedures based on cell surface markers. Comparison between the dose-response curves obtained with type I and type II interferons suggest that both interferon preparations stimulate NK activity in a comparable manner. We could conclude that interferon molecules (type I as well as type II) display a positive immunoregulatory function on NK cells.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6157349

Source DB:  PubMed          Journal:  Ann Immunol (Paris)        ISSN: 0300-4910


  15 in total

Review 1.  Intestinal inflammation and colorectal cancer: a double-edged sword?

Authors:  Angelamaria Rizzo; Francesco Pallone; Giovanni Monteleone; Massimo Claudio Fantini
Journal:  World J Gastroenterol       Date:  2011-07-14       Impact factor: 5.742

2.  Selective impairment of alpha-interferon-mediated natural killer augmentation in Sjögren's syndrome: differential effects of alpha-interferon, gamma-interferon, and interleukin 2 on cytolytic activity.

Authors:  A Takeda; N Minato; S Kano
Journal:  Clin Exp Immunol       Date:  1987-11       Impact factor: 4.330

Review 3.  Natural killer activity: early days, advances, and seminal observations.

Authors:  John R Ortaldo; Robert H Wiltrout; Craig W Reynolds
Journal:  Crit Rev Oncog       Date:  2014

4.  Biosynthetic human interferon treatment of herpetic keratitis.

Authors:  G Smolin
Journal:  Trans Am Ophthalmol Soc       Date:  1983

5.  Stimulation natural cytotoxic activity in mixed cell cultures and by culture supernatants containing interferon.

Authors:  M R Potter; M Moore; A G Morris
Journal:  Immunology       Date:  1982-06       Impact factor: 7.397

6.  Inhibition of in vitro natural killer activity by the third component of complement: role for the C3a fragment.

Authors:  C Charriaut; A Senik; J P Kolb; M Barel; R Frade
Journal:  Proc Natl Acad Sci U S A       Date:  1982-10       Impact factor: 11.205

7.  Regulation of natural and antibody-dependent cellular cytotoxicity by staphylococcal enterotoxin A.

Authors:  I Kimber; T Bakács; M Moore
Journal:  Clin Exp Immunol       Date:  1983-10       Impact factor: 4.330

8.  Tuberculin hypersensitivity hepatitis in mice infected with Mycobacterium bovis (BCG).

Authors:  J Ferluga
Journal:  Am J Pathol       Date:  1981-10       Impact factor: 4.307

9.  T-cell response to phytohemagglutinin in the interferon-γ release assay as a potential biomarker for the response to immune checkpoint inhibitors in patients with non-small cell lung cancer.

Authors:  Chisato Kamimaki; Nobuaki Kobayashi; Momo Hirata; Kohei Somekawa; Nobuhiko Fukuda; Sousuke Kubo; Seigo Katakura; Shuhei Teranishi; Keisuke Watanabe; Nobuyuki Horita; Yu Hara; Masaki Yamamoto; Makoto Kudo; Hongmei Piao; Takeshi Kaneko
Journal:  Thorac Cancer       Date:  2021-05-04       Impact factor: 3.500

10.  Th17-type cytokines, IL-6 and TNF-α synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growth.

Authors:  V De Simone; E Franzè; G Ronchetti; A Colantoni; M C Fantini; D Di Fusco; G S Sica; P Sileri; T T MacDonald; F Pallone; G Monteleone; C Stolfi
Journal:  Oncogene       Date:  2014-09-01       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.